Entrepreneur & CEO of Orphagen Pharmaceuticals
- Greater San Diego Area
Scott Thacher's Overview
- CEO at Orphagen Pharmaceuticals
- Board of Directors at Io Therapeutics
- President at San Diego Entrepreneurs Exchange
- Harvard University
- Stanford University
Scott Thacher's Experience
April 2001 – Present (13 years 6 months) San Diego
Orphagen Pharmaceuticals is an emerging R&D-based pharmaceutical company located in San Diego, California.
The Company addresses major unmet medical needs by developing innovative small molecule drugs targeting orphan nuclear receptors. We have hits and leads to several orphan nuclear receptors in various stages of preclinical discovery research.
To date, Orphagen has secured $5 M in external grant funding and a major corporate partnership to support its drug discovery programs.
Research Investigator/Principal Investigator
Public Company; 10,001+ employees; AGN; Pharmaceuticals industry
March 1993 – March 2001 (8 years 1 month)
Directed research programs in retinoid therapeutics for acne, psoriasis, and diabetes. Member of management team for alliances with Warner-Lambert (in diabetes) and Cytochroma (topical agents for acne).
Educational Institution; 1001-5000 employees; Higher Education industry
1980 – 1984 (4 years)
Scott Thacher's Education
Activities and Societies: News Editor, Stanford Daily
Scott Thacher's Additional Information
Contact Scott for:
- new ventures
- expertise requests
- business deals
- reference requests
- getting back in touch